Leaflet RUDIVAX LIVE ATTENUATED RUBELLA VACCINE 1000 DICC50 / 0.5ml lyophilisate and solvent for suspension for injection

Indicated for: prevention of measles, mumps and rubella

Route of administration: injectable

Substance: live attenuated rubella vaccine (vaccine)

ATC: J07BJ01 (Antiinfectives for systemic use | Viral vaccines | Rubella vaccines)

Precautions:
Anaphylaxis
Anaphylaxis

Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.

Contraindicated during pregnancy
Contraindicated during pregnancy

Do not use this medicine during pregnancy.

Avoid live vaccines
Avoid live vaccines

Avoid live vaccines during treatment if contraindicated.

Additional monitoring
Additional monitoring

This medicine is subject to additional monitoring.

Refrigerated storage
Refrigerated storage

Store in the refrigerator as instructed in the leaflet.

Protect from light
Protect from light

Store protected from light.

The live attenuated rubella vaccine is used to prevent rubella, a contagious viral disease caused by the rubella virus. The vaccine contains a weakened form of the virus, which stimulates the immune system to produce specific antibodies against it, providing long-term protection against infection.

The vaccine is administered subcutaneously, usually in two doses, with the first dose given at 12-15 months of age and the second between 4 and 6 years. It is recommended for children and adults who have not been previously vaccinated or have not had rubella.

Common side effects include fever, rashes, pain, or swelling at the injection site. In rare cases, severe adverse reactions such as allergic reactions or transient arthralgia may occur.

The live attenuated rubella vaccine is an essential preventive measure for reducing the incidence of rubella and its associated complications, such as congenital rubella syndrome in pregnant women.

General data about RUDIVAX LIVE ATTENUATED RUBELLA VACCINE 1000 DICC50 / 0.5ml

  • Substance: live attenuated rubella vaccine
  • Date of latest medicines list: 01-07-2013
  • Product code: W13340005
  • Concentration: 1000 DICC50 / 0.5ml
  • Pharmaceutical form: lyophilisate and solvent for suspension for injection
  • Quantity: 10
  • Product type: Generic medicine
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.